1. Home
  2. FOLD vs SONO Comparison

FOLD vs SONO Comparison

Compare FOLD & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$9.92

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Sonos Inc.

SONO

Sonos Inc.

HOLD

Current Price

$18.71

Market Cap

2.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
SONO
Founded
2002
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Video Chains
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.2B
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
FOLD
SONO
Price
$9.92
$18.71
Analyst Decision
Buy
Strong Buy
Analyst Count
7
3
Target Price
$30.29
$17.00
AVG Volume (30 Days)
4.6M
1.6M
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$598,704,000.00
$1,443,276,000.00
Revenue This Year
$21.12
$4.35
Revenue Next Year
$21.23
$7.90
P/E Ratio
N/A
N/A
Revenue Growth
21.28
N/A
52 Week Low
$5.51
$7.63
52 Week High
$10.57
$19.08

Technical Indicators

Market Signals
Indicator
FOLD
SONO
Relative Strength Index (RSI) 64.67 64.83
Support Level $9.56 $18.16
Resistance Level $10.05 $19.08
Average True Range (ATR) 0.37 0.65
MACD -0.02 0.21
Stochastic Oscillator 51.14 89.27

Price Performance

Historical Comparison
FOLD
SONO

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

Share on Social Networks: